Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carol O'Neill

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Headache|September 13, 2013
Sumatriptan iontophoretic transdermal system: history, study results, and use in clinical practiceMark Pierce, Carol O'Neill, Ezra Felker, et al.
Headache|April 9, 2014
Sumatriptan transdermal system can be correctly assembled and applied during migraine attacksKappa P Meadows, Mark Pierce, Carol O'Neill, et al.
Reviews in Urology|September 21, 2006
Early Response Time in Sexual Activity and Mood Following Testosterone Gel Replacement in Hypogonadal Males from the Testim(R) START StudyEdward Loizides, Mark J Swierzewski, Carol O'neill, et al.
Headache|May 15, 2009
Zelrix: a novel transdermal formulation of sumatriptanMark Pierce, Thomas Marbury, Carol O'Neill, et al.
Cannabis and Cannabinoid Research|September 2, 2017
Identification of Psychoactive Degradants of Cannabidiol in Simulated Gastric and Physiological FluidJohn Merrick, Brian Lane, Terri Sebree, et al.
Pharmaceutical Research|June 20, 2007
A unique iontophoretic patch for optimal transdermal delivery of sumatriptanSteven J Siegel, Carol O'Neill, Louise M Dubé, et al.
Journal of Neurodevelopmental Disorders|August 3, 2019
A phase 1/2, open-label assessment of the safety, tolerability, and efficacy of transdermal cannabidiol (ZYN002) for the treatment of pediatric fragile X syndromeHelen Heussler, Jonathan Cohen, Natalie Silove, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Headache|September 13, 2013
Sumatriptan iontophoretic transdermal system: history, study results, and use in clinical practiceMark Pierce, Carol O'Neill, Ezra Felker, et al.
Headache|April 9, 2014
Sumatriptan transdermal system can be correctly assembled and applied during migraine attacksKappa P Meadows, Mark Pierce, Carol O'Neill, et al.
Reviews in Urology|September 21, 2006
Early Response Time in Sexual Activity and Mood Following Testosterone Gel Replacement in Hypogonadal Males from the Testim(R) START StudyEdward Loizides, Mark J Swierzewski, Carol O'neill, et al.
Headache|May 15, 2009
Zelrix: a novel transdermal formulation of sumatriptanMark Pierce, Thomas Marbury, Carol O'Neill, et al.
Cannabis and Cannabinoid Research|September 2, 2017
Identification of Psychoactive Degradants of Cannabidiol in Simulated Gastric and Physiological FluidJohn Merrick, Brian Lane, Terri Sebree, et al.
Pharmaceutical Research|June 20, 2007
A unique iontophoretic patch for optimal transdermal delivery of sumatriptanSteven J Siegel, Carol O'Neill, Louise M Dubé, et al.
Journal of Neurodevelopmental Disorders|August 3, 2019
A phase 1/2, open-label assessment of the safety, tolerability, and efficacy of transdermal cannabidiol (ZYN002) for the treatment of pediatric fragile X syndromeHelen Heussler, Jonathan Cohen, Natalie Silove, et al.
Pageof 1